5CV — CureVac NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual balance sheet for CureVac NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	20-F	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	31.1	1,323	813	498	404
Net Total Accounts Receivable
Net Total Receivables	18.7	4.01	21.2	11.6	23
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	57.2	1,390	940	584	478
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	61.7	101	200	242	279
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	131	1,511	1,158	860	788
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28.1	248	358	156	186
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	173	800	470	327	271
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-42.8	711	688	533	517
Total Liabilities & Shareholders' Equity	131	1,511	1,158	860	788
Total Common Shares Outstanding